Age: 46.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: second dose: has the delta variant; second dose: has the delta variant; second dose: allergies; pulmonary nodules in her lungs; lymph nodes swelling; asthma; second dose- lymphadenopathy on both sides; second dose: fever; second dose: coughing; second dose: stated that she became flushed; This is a spontaneous report from a contactable consumer (patient) via Pfizer sponsored program. A 46-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0171 and Expiry date was not reported), via intramuscular route of administration administered in Arm Left on 22Apr2021 (at the age of 46-years-old) as dose 2, single for COVID-19 immunization. Medical history included hypersensitivity from 13Jul2021 and ongoing Verbatim: allergies, asthma from 13Jul2021 and ongoing Verbatim: Asthma, stress from 2010 and ongoing Verbatim: PTSD. Concomitant medication includes: other medications for other conditions (unspecified date). No further details provided. Patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot Number: EP69SS and Expiry date was not reported), via intramuscular route of administration on 27Mar2021 (at the age of 46-years-old) in Arm Left as dose 1, single for COVID-19 immunization and experienced Blistering of fingers bilaterally, Palm of hands were burning and Swelling of the fingers bilaterally. Patient who has a history of asthma that received the Pfizer BioNTech Covid 19 vaccine in April. Stated that she had a reaction with each injection. Stated that with the second one she had lymphadenopathy on both sides. Stated that she was on steroids and antibiotics. Stated that one side was still swollen. Stated that she has pulmonary nodules in her lungs. Stated that she has the delta variant. Wanted to know if she needed the booster vaccine. Stated that since she had reaction to first two doses will the booster vaccine benefit her. Wanted to know once over delta variant and well enough for booster should she attempt since she had two adverse reactions to two doses. Stated that on Jun 2020 had CT of lungs had bilateral midlobe pulmonary nodules. Stated that she has them bilaterally upper and lower lobes and still to her middle lobes prior to the vaccine. Stated that whenever her immune system kicks in that the blistering of fingers and swelling and palms of hands burning flare up. Stated that in seven hours after the vaccine that her lymph nodes swelling. Stated that the left side was still swollen. Stated she was treated with prednisone and antibiotics. Stated two days ago she became flushed and had a low grade temperature of 99.8. Stated that she noticed increased coughing which she attributed to allergies and asthma because she was allergic to things in her backyard. Stated that the coughing was worst and the fever increased yesterday so she got the home test and the test came back positive. Stated that she went to the emergency room yesterday for them to do blood work and swabbing and the variant came back as delta. Stated that she just got those results this morning. Stated that the cough was productive. Stated that her fever is 99.0 axillary digitally. Treatment information was given as none for the symptoms of the hands. Stated that she takes Advil dual for fever. Stated that if she misses a dose then the fever spikes. She had the second dose on 22Apr2021 where she experienced lymphadenopathy. And now she has the Delta variant. She wanted to know if she should take the booster or third shot. She had already asked the pharmacy and CDC but they did not give her a clear recommendation. She also mentioned that she was currently being pre-screened for cancer and if she will test positive for cancer she might be eligible for the booster shot. The patient underwent lab tests and procedures which included body temperature: 99.0 fahrenheit on, body temperature: 99.8 fahrenheit on 2021 , computerised tomogram: unknown on Jun2020 had bilateral midlobe pulmonary nodules , sars-cov-2 test: positive on 22Aug2021. The outcome of the event second dose- lymphadenopathy on both sides was recovering and rest all events was not recovered.  No follow-up attempts are possible. No further information is expected.